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live full, economically active lives will be condemned to a premature, 
preventable death. 
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The World Health Organization (WHO) estimates that there are 
10 million new cases of tuberculosis (TB) reported worldwide each 
year, and 1.7 million people die from the disease.1 The incidence of 
TB in sub-Saharan Africa (SSA) remains very high at over 300 new 
cases of TB per 100 000 population in 2007.2 The TB epidemic in 
SSA is fuelled by the HIV epidemic, and up to 70% of adults with 
TB are co-infected with HIV.2 There are few data on drug-resistant 
TB from SSA,3 probably owing to poor TB programme performance, 
inadequate laboratory facilities for drug susceptibility testing (DST), 
and poor surveillance, data collection and reporting procedures. The 
WHO estimated that 69 000 cases of MDR-TB emerged in 2008 in 
Africa, which is most probably an underestimate.1
The global focus on TB control is on early diagnosis and treatment 
of people in the community in high TB- and TB/HIV-endemic 
countries. People concentrated in confined situations, such as prisons, 
are important but often neglected reservoirs for TB transmission, and 
threaten those in the outside community. The European Academies 
of Sciences Advisory Committee on drug-resistant TB in Europe 
emphasised the poor TB control in prisons and the rapid spread of TB 
between prisoners and prison staff.4 Data from SSA prisons indicate 
a similar ominous situation in prisons in Africa. The prevalence of 
TB in SSA prisons is estimated to be 6 - 30 times higher than that in 
the general population.5 The TB incidence rate in Zambian prisons 
is 5 285 cases per 100 000 inmates per year,which is about 10 times 
that of the outside population.6 A Center for Disease Control study 
of Botswanian prisons led to important recommendations, including 
active screening, contact investigation, reduction of transmission, 
and isoniazid preventative therapy for HIV-positive prison inmates 
and guards.7
TB in prisons threatens inmates and prison staff (wardens, cooks, 
clinical staff etc.), who are at particular risk of acquiring TB because 
of the conditions and working environment. Staff also interact with 
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their families and community and may thus transmit the disease 
further. The restricted and confined conditions for prisoners and 
prison staff, poor nutrition, poor ventilation, stress and inadequate 
prison health services, conduce to the emergence and enhanced 
transmission of drug-resistant TB, which may then spread into the 
community.
Alarming data from SSA show that the incidence of multi- and 
extensively drug-resistant tuberculosis (MDR-TB and XDR-TB) 
is increasing.7-9 Drug-resistant TB threatens all SSA national TB 
programmes because of problems with rapid identification, providing 
appropriate and effective treatment, and poor treatment outcomes.10,11 
Disease surveillance and reporting of TB in prisons is often weak or 
non-existent, and the problem of TB and drug-resistant TB remains 
poorly defined. The WHO status report12 on TB in prisons reports an 
urgent need to ensure effective and efficient diagnosis and treatment 
of drug-resistant forms of TB. It recommends the development of an 
effective national TB programme to reduce the emergence of new 
drug-resistant strains of Mycobacterium tuberculosis, both inside and 
outside prisons, by effectively detecting and treating all MDR-TB 
cases. However, these guidelines have generally been ignored and not 
implemented in SSA, illustrating the large gap between the WHO 
recommendations and the reality in SSA prisons. Drug-resistant TB 
has been demonstrated in Zambian8 and Botswanian7 prisons. These 
countries have no data on drug-resistant TB in prisons or adequate 
drug resistance surveillance systems in place, 7 years after the studies. 
An article entitled Death and disease in Zimbabwe’s prisons describes 
the terrible conditions faced by prisoners in SSA.9 Overcrowding, 
poor nutrition, poor sanitation, HIV infection and poor health care 
are obvious causes for the escalating death toll in Zimbabwe’s prisons; 
TB is reported as the biggest killer disease.
Prisons in SSA have no proper isolation facilities to treat MDR/
XDR-TB. Such facilities are also scarce in district and referral 
hospitals, highlighting this wider problem. Since many XDR-TB 
patients are untreatable, where should prison inmates with XDR-TB 
be housed and what will happen to them? There is a great need to 
improve prison health services and to introduce rapid point-of-care 
diagnostics for TB and screening for drug resistance in prisons.13 
Recommendations for infection control isolation of patients and 
protection of medical staff apply to all institutions but are not in place 
and not practical or applicable in SSA prisons. Isolation of prison 
inmates with active TB during the infectious phase is important 
for TB control but is impossible in the SSA prison infrastructure. 
The best method of infection control remains the early diagnosis of 
infectious cases and the prompt initiation of effective treatment to 
prevent the emergence of drug-resistant TB.
Treatment of MDR/XDR-TB is expensive and will stress national 
health budgets. Without basic epidemiological data, it is difficult to 
justify investment to improve health services for prisoners in the face 
of competition for limited national budgets and resources by other 
important health problem areas. TB control will not be achieved in 
SSA until governments focus and take action on all aspects of the 
TB problem, which must include TB in confined institutions such as 
prisons. Other serious infectious diseases are also rapidly transmitted 
in prisons, including HIV, respiratory and skin infections, and STDs. 
Serious political and funding attention is required urgently14 to 
improve health services in SSA to prevent the potential time bomb 
of drug-resistant TB exploding and undermining the gains of TB 
control programmes.
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